People: Novartis AG (NVS)
17 Jan 2019
Dr. Vasant (Vas) Narasimhan, M.D., is Member of the Executive Committee at Novartis Inc. He was Global Head of Drug Development and Chief Medical Officer for Novartis, Member of the Executive Committee of Novartis Inc. from February 1, 2016. Dr. Narasimhan previously was Global Head of Development for Novartis Pharmaceuticals, overseeing the entire general medicines pipeline. He has also served as Global Head of the Sandoz Biopharmaceuticals and Oncology Injectables business unit, Global Head of Development for Novartis Vaccines, North America Region Head for Novartis Vaccines, and United States Country President for Novartis Vaccines and Diagnostics. Before joining Novartis in 2005, he worked at McKinsey & Company. Dr. Narasimhan received his medical degree from Harvard Medical School in the US, a master’s degree in public policy from Harvard’s John F. Kennedy School of Government, and a bachelor’s degree in biological sciences from the University of Chicago. During and after his medical studies, he worked on a range of public health issues in developing countries. He is an elected member of the United States National Academy of Medicine and serves on the board of fellows of Harvard Medical School.
|Total Annual Compensation, CHF||2,456,700|
|Restricted Stock Awards, CHF||--|
|Long-Term Incentive Plans, CHF||1,870,010|
|All Other, CHF||219,165|
|Fiscal Year Total, CHF||4,545,870|